Reduction of the cycle of lyophilization of the vaccine atenuated Yellow Fever presentation 02 and 05 doses of Bio-Manguinhos

Introduction: With the outbreak of Yellow Fever in mid-2017, WHO recommended vaccination in risk areas and other regions of Brazil, made it necessary to increase the vaccine offer at the national level (PNI) and also international, backed by law 13801 -2019 sanctioned by the federal government in January 2019 which increases the Institutional commitment with the supply of vaccines for PAHO and UNICEF (www.fiocruzbrasilia.fiocruz.br). Bio-Manguinhos, maintaining an institutional commitment to the supply of vaccines, has articulated to increase its productive capacity without generating additional financial costs as well as to increase the supply of this vaccine through the optimization of its freeze-drying cycle.